Paclitaxel, a naturally occurring antimicrotubule agent, has been demonstra
ted to possess significant cell-killing activity in a variety of tumor cell
s through induction of apoptosis. It is currently unclear whether this find
ing suggests a novel mechanism of action for paclitaxel against tumor cells
or just represents an end product of the well-known action of paclitaxel o
n microtubules and cell cycle arrest. Morphologically, a sustained block of
mitosis seems to be required for paclitaxel-induced apoptosis because most
apoptotic events are observed to occur in cells showing a prior mitotic ar
rest. However, this morphological correlation alone does not prove that pac
litaxel-induced apoptosis is indeed a secondary event resulting from mitoti
c arrest. Instead, several lines of evidence obtained from recent studies h
ave suggested that apoptotic cell death induced by paclitaxel may occur via
a signaling pathway independent of microtubules and G(2)/M arrest. BIOCHEM
PHARMACOL 57;11:1215-1221, 1999. (C) 1999 Elsevier Science Inc.